Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Visiopharm's AI-Powered Image Analysis Software Selected to Analyze the Largest Collection of Human Pathology Specimens in the World 2020-11-17 16:17
INOVIO Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical Trial for its COVID-19 DNA Vaccine Candidate, INO-4800; Trial Will Be Funded by the U.S. Department of Defense 2020-11-16 20:00
Cytiva supports Clover Biopharmaceuticals to scale up the output of its vaccine candidate 2020-11-16 14:00
Innovent Announces the Results of the Phase I Clinical Trial of IBI302, a First-in-class Ophthalmic Recombinant Human Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2020 American Academy of Ophthalmology 2020-11-16 08:00
PTC Therapeutics Announces Initiation of Phase 2/3 Clinical Trial in Australia to Evaluate PTC299 for the Treatment of COVID-19 2020-11-16 05:00
Biortus Announces Round A Financing and Launches Global Cryo-EM Innovation Center 2020-11-14 12:40
The third CIIE concludes, $72.6 billion in intended deals for the coming year inked 2020-11-14 03:21
China Biologic Products to Report Third Quarter 2020 Financial Results 2020-11-13 21:00
Positive Results from RhoVac's Clinical Phase I/II Study published in Journal of ImmunoTherapy of Cancer 2020-11-13 17:53
Molecular Stethoscope Announces Completion of its NAFLD/NASH Study and Podium Presentation of Results by Dr. Naga Chalasani at the AASLD Liver Meeting 2020 2020-11-13 04:19
XJTLU launches new Academy of Pharmacy 2020-11-12 15:13
CStone Pharmaceuticals Announces China's NMPA has Accepted its New Drug Application for anti-PD-L1 Monoclonal Antibody Sugemalimab in First-Line Advanced NSCLC 2020-11-12 10:58
Suh Kyungbae Science Foundation holds the first symposium 2020-11-12 08:00
I-Mab Announces Preclinical Data on Differentiated Anti-C5aR Antibody TJ210/MOR210 at SITC 2020 2020-11-11 21:00
Innovation Drives Excellence, Innovent Successfully Held 2020 Virtual R&D Day 2020-11-11 08:00
FibroGenesis Announces the Filing of its 250th Patent for Fibroblast Cell Therapy Platform 2020-11-10 22:37
Bioheng Announced Oral Presentation of Its Preliminary Results of CRISPR-Engineered Allogeneic CAR-T for r/r B-ALL Treatment at 2020 ASH Meeting 2020-11-10 22:30
I-Mab Reports Phase 1 Clinical Trial Data of Highly Differentiated Anti-CD47 Monoclonal Antibody Lemzoparlimab at the 2020 SITC Annual Meeting 2020-11-09 21:12
VolitionRx Limited Schedules Third Quarter 2020 Earnings Conference Call and Business Update 2020-11-09 21:00
GenScript Receives FDA Emergency Use Authorization for World's First SARS-CoV-2 Neutralizing Antibody Detection Kit 2020-11-09 20:30
1 232 233 234 235 236 413